Antidiabetic and cytotoxic activities of methanolic extract of tabernaemontana divaricata (L.) flowers

International Journal of Drug Development and Research

Volumn 3, Issue 3, 2011, Pages 270-276

  Rahman, Masudur ^a   Islam, Md Saiful ^a   Ali, Md Sekendar ^a   Islam, Md Rafikul ^a   Hossain, Md Zakir ^b  

^a INTERNATIONAL ISLAMIC UNIVERSITY CHITTAGONG   (Bangladesh)

^b UNIVERSITY OF RAJSHAHI   (Bangladesh)

Author keywords

Alloxan; Cytotoxicity; Diabetes; Tabernaemontana divaricata

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; METFORMIN; METHANOL; PLANT EXTRACT; TABERNAEMONTANA DIVARICATA EXTRACT; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; FLOWER; GLUCOSE BLOOD LEVEL; LETHALITY; MALE; MOUSE; NONHUMAN; STANDARD;

EID: 83055181706     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. International Diabetes Federation. Diabetes atlas. 3rd Edition. Brussels: International Diabetes Federation, 2006.
2. Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. Achievement and future development 1997; 54: 355-368.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5).
5. L Pirart. Diabetes mellitus and its degenerative complieations: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 168-172.
6. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147(6):386-99.
7. Holman RR, Turner RC. Oral Agents and Insulin in the Treatment of NIDDM. In: Pickup J. and G. Wiliams (Eds.), Textbook of Diabetes, Blackwell, Oxford, 1991; pp 407-469.
8. Arambewela LSR, Ranatunge T. Indole alkaloid from Tabernaemontana divaricata. Phytochemistry 1991; 3: 1740-1.
9. Kam TS, Anuradha S. Alkaloids from Tabernaemontana divaricata. Phytochemistry 1995; 40: 313-6.
10. Fulton DC, Kroon PA, Threlfall DR. Enzymological aspects of the redirection of terpenoid biosynthesis in elicitor-treated cultures of Tabernaemontana divaricata. Phytochemistry 1994; 35: 1183-6.
11. Sierra MI. Biochemical, molecular and physiological aspects of plant peroxidases. Geneva: Imprimerie National 1991.
12. Van Beek TA, Verpoorte R, Svendsen AB, Leeuwenberg AJ, Bisset NG. Tabernaemontana L. (Apocynaceae): a review of its taxonomy, phytochemistry, ethnobotany and pharmacology. J Ethnopharmacol 1984; 10: 1-156.
13. Sharker SM, Chakma S and Rahman AA. Phytochemical and antinociceptive study of leaves of Tabernaemontana divaricata (L). Journal of Medicinal Plants Research 2011; 5(2): 245-247.
14. Jaju S. Antimicrobial and antioxidant activity of the leaves of Tabernaemontana divaricata. International Herbal Conference 2009, Bangalore, India.
15. Alex AC. In-vitro anti-inflammatory activity studies of the latex of Tabernaemontana divaricata by human red blood cell stabilization method. International Herbal Conference 2009; Bangalore, India.
16. Pratchayasakul W, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. Reversible acetylcholinesterase inhibitory effect of Tabernaemontana divaricata extract on synaptic transmission in rat CA1 hippocampus. Indian J Med Res 2010; 131: 411-417.
17. Meyer BN, NR Ferrigni, JE Putnam, JE Jacobsen, DE Nichols, JL McLaughlin. Brine shrimp: A convenient general bioassay for active plants constituents. J. Med. Plant Res 1982; 45: 31-34.
18. Jorns A, Munday R, Tiedge M, Lenzen S. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro. J Endocrinol 1997; 155: 283-293.
19. WHO(2008). Traditional medicine. http://www.who.int/mediacentre/factsheets/fs134/en/